Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20113899 | 0.82 | MEN1 (0.49) | MEN1KMT2ANR1I2ALDH1A1LMNA | |
| SCHEMBL20109159 | 0.74 | KDM1A (0.40) | KDM1AMEN1KMT2ANR1I2ALDH1A1 | |
| SCHEMBL20109133 | 0.71 | TSHR (0.40) | KDM1AMEN1KMT2ANR1I2ALDH1A1 | |
| SCHEMBL20109235 | 0.65 | SMN1; SMN2 (0.40) | KDM1AMEN1KMT2ANR1I2ALDH1A1 | |
| SCHEMBL7855199 | 0.64 | KDM1A (0.48) | KDM1AMEN1KMT2ANR1I2ALDH1A1 | |
| SCHEMBL59713 | 0.64 | KDM1A (0.48) | KDM1AMEN1KMT2ANR1I2ALDH1A1 | |
| SCHEMBL8038875 | 0.64 | MEN1 (0.63) | MEN1KMT2ANR1I2ALDH1A1TSHR | |
| SCHEMBL667799 | 0.63 | RECQL (0.53) | KDM1AMEN1KMT2ANR1I2ALDH1A1 | |
| SCHEMBL667800 | 0.63 | RECQL (0.53) | KDM1AMEN1KMT2ANR1I2ALDH1A1 | |
| SCHEMBL598599 | 0.63 | TSHR (0.50) | KDM1AMEN1KMT2ANR1I2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118770-A1 | N-Heterocyclic Phosphines | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118770-A1 | N-Heterocyclic Phosphines | NANP, PPIP5K2, PHPT1 | KDM1A 4434/4885MEN1 469/4885KMT2A 2508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.